查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1930069

全球腎結石治療市場：市場規模、佔有率、成長率、產業分析、依類型、應用和地區劃分的考察、未來預測（2026-2034）

Kidney Stone Management Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 135 Pages | 商品交期: 請詢問到貨日

價格

腎結石治療市場成長驅動因素

2025年，全球腎結石治療市場規模為19.8億美元。預計到2026年，該市場將成長至20.9億美元，到2034年將達到33.7億美元，這反映了在疾病盛行率上升和微創治療廣泛應用的推動下，該市場正穩步擴張。北美地區引領腎結石治療市場，2025年佔據36.03%的市場。這得益於先進的醫療基礎設施、高診斷率以及充足的高科技醫療設備供應。

腎結石影響相當一部分成年人，其10年復發率超過30%。肥胖、糖尿病、高血壓和久坐不動的生活方式日益普遍，增加了結石形成的風險，推動了醫院和門診對腎結石治療設備的持續需求。

市場驅動因素與成長因素

微創手術技術的日益普及是腎結石治療市場最強的驅動因素之一。輸尿管鏡碎石術、體外震波碎石術和經皮腎鏡取石術等手術因其術後疼痛減輕、併發症發生率降低、住院時間縮短和恢復速度加快等優勢而廣泛採用。外科醫生逐漸減少開放性手術，提高了手術量和設備利用率。

柔性光纖輸尿管鏡、數位影像系統和雷射碎石平台等技術進步提高手術精度和臨床成功率。高能钬雷射系統等創新技術能夠有效碎石，同時最大限度地減少對周圍組織的損傷，改善治療效果，並鼓勵醫院投資先進的泌尿外科設備。

市場限制與挑戰

儘管技術不斷進步，但某些治療方法仍存在局限性。體外震波碎石術（ESWL）存在一些風險，包括腎組織損傷、出血、尿路阻塞和潛在的動脈血壓升高。這些副作用在某些情況下可能會限制患者和醫生的選擇，並阻礙其在複雜結石病例中的廣泛應用。

此外，成本障礙也會影響發展中地區的推廣，因為這些地區的醫療預算有限，且難以獲得先進的手術設備。此外，農村醫療機構（尤其是在新興經濟體）缺乏專業的泌尿外科基礎設施，也限制了病患獲得治療的機會。

新冠疫情對市場的影響

新冠疫情暫時中斷了腎結石治療服務。擇期泌尿外科手術被推遲，診斷諮詢減少，醫療資源被重新分配到急診和感染控制。醫療器材生產和全球供應鏈也放緩，導致設備採購延遲。雖然疫情後需求恢復，但手術積壓導致醫院和門診手術中心的醫療器材使用量出現短期波動。

市場區隔分析

依類型

此市場細分包括體外震波碎石術、輸尿管鏡檢查和經皮腎鏡取石術（PCNL）。其中，輸尿管鏡檢查將佔據領先地位，到2026年將佔市場佔有率的51.59%。這項優勢主要得益於其較高的結石清除率、較低的復發風險以及對中小結石的高度適用性。內視鏡的靈活性、影像清晰度和雷射相容性的不斷提升，推動其進一步普及。

依最終使用者劃分

依最終使用者劃分，市場由醫院、專科診所和門診手術中心組成。醫院將佔據最大的市場佔有率，到2026年將佔市場佔有率的55.89%，這主要得益於其龐大的患者數量、完善的手術設施以及廣泛的保險覆蓋範圍。專科診所因其在泌尿外科領域的專業知識、不斷擴大的門診手術能力以及某些國家優惠的償付政策而備受關注。

依地區劃分的市場趨勢

北美

預計到2025年，北美市場規模將達到7.1億美元，憑藉較高的診斷普及率、有利的償付制度以及技術的快速普及，北美將繼續保持其區域領先地位。受微創手術的廣泛應用和較高的疾病盛行率推動，美國腎結石治療市場預計到2026年將達到6.8億美元。

歐洲

歐洲是第二大地區，其市場規模主要受發病率和醫療保健支出成長的推動。預計2026年，德國市場規模將達到1.6億美元，英國市場規模將達7,000萬美元。這得歸功於先進泌尿外科設備的高度普及以及公共醫療保健網路中完善的轉診系統。

亞太地區

由於患者群體龐大且醫療服務可及性不斷提高，亞太地區預計將實現顯著成長。到2026年，中國市場預計將達到 1.4億美元，日本市場將達到 1.1億美元，印度市場將達到 5,000萬美元。人們健康意識的提高、醫院投資的增加以及私人醫療服務的擴張，推動城市治療中心對相關設備的需求。

拉丁美洲、中東和非洲

在醫療基礎設施改善和疾病認知度提高的推動下，這些地區正經歷溫和成長。醫院網路的擴展和國際醫療器材合作改善腎結石治療技術的可近性。

競爭格局與產業趨勢

該市場由Boston Scientific Corporation、Olympus Corporation、KARL STORZ SE & Co. KG、Richard Wolf GmbH、Cook Medical、Lumenis、EDAP TMS等公司引領。這些公司憑藉著多元化的產品組合、持續的技術創新和策略聯盟，保持著強大的全球影響力。

關鍵產業趨勢包括推出先進的柔性輸尿管鏡取石系統和高能量雷射平台，目的是提高手術效率和安全性。雷射碎石技術在新興市場的推廣應用，進一步提升了醫療器材的普及率，並增強了全球製造商的競爭力。

報告範圍

《全球腎結石治療市場》報告詳細分析了市場規模、依類型和最終用戶劃分的市場細分、區域趨勢、技術趨勢、競爭策略和新產品發布。本報告評估了影響泌尿外科設備市場在2025年、2026年和2034年發展的成長因素、營運挑戰、醫療政策影響以及手術應用模式，為泌尿外科設備行業的製造商、醫療服務提供者、投資者和策略規劃人員提供全面的洞察。

輸尿管鏡、雷射碎石術和數位成像平台的技術進步顯著提高了手術成功率，減少了併發症，縮短了恢復時間，促使醫院和專科診所升級其泌尿外科設備。輸尿管鏡領域在2026年的市場佔有率將達到 51.59%，而醫院的市場佔有率也將達到 55.89%，這凸顯了人們對先進的、以醫療機構為基礎的治療方案的持續偏好。

目錄

第1章 引言

第2章 執行摘要

第3章 市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機會

第4章 主要考察

  • 主要國家和地區的償付情況
  • 腎結石治療設備的最新進展
  • 主要行業趨勢
  • 主要產業趨勢：併購、業務合作
  • 新冠疫情對腎結石治療設備市場的影響

第5章 全球腎結石治療市場分析、洞察與預測（2021-2034）

  • 關鍵分析/摘要
  • 市場分析、洞察與預測：依類型劃分
    • 體外震波碎石術
    • 輸尿管鏡檢查
    • 經皮腎鏡取石術（PCNL）
  • 市場分析、洞察與預測：依最終用戶劃分
    • 醫院
    • 專科診所
    • 門診手術中心
  • 市場分析、洞察與預測：依地區劃分
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第6章 北美腎結石治療市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 美國
    • 加拿大

第7章 歐洲腎結石治療市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 斯堪的納維亞
    • 歐洲其他地區

第8章 亞太地區腎結石治療市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 東南亞亞洲
    • 亞太其他地區

第9章 拉丁美洲腎結石治療市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區

第10章 中東與非洲腎結石治療市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • GCC各國
    • 南非
    • 中東和非洲其他地區

第11章 競爭分析

  • 主要行業趨勢
  • 全球市場佔有率分析（2021）
  • 競爭格局概覽
  • 主要參與者比較分析
  • 公司簡介
  • Cook Medical Inc.
  • Olympus Corp.
  • C.R. Bard Inc.
  • Boston Scientific Corporation
  • STORZ MEDICAL AG
  • Richard Wolf GmbH
  • Lumenis
  • EDAP TMS
  • DirexGroup
  • DirexGroup
  • 其他主要參與者

第12章 策略建議

Product Code: FBI100450

Growth Factors of kidney stone management Market

The global kidney stone management market size was valued at USD 1.98 billion in 2025. The market is projected to grow to USD 2.09 billion in 2026 and further reach USD 3.37 billion by 2034, reflecting steady expansion driven by increasing disease prevalence and rising adoption of minimally invasive treatment procedures. North America dominated the kidney stone management market with a 36.03% market share in 2025, supported by advanced healthcare infrastructure, higher diagnosis rates, and strong availability of technologically advanced medical devices.

Kidney stone disease, also known as nephrolithiasis, affects a significant portion of the adult population, with recurrence rates exceeding 30% within ten years. The growing burden of obesity, diabetes, hypertension, and sedentary lifestyles is increasing the risk of stone formation, thereby driving sustained demand for kidney stone treatment devices across hospital and outpatient settings.

Market Drivers and Growth Factors

The increasing preference for minimally invasive surgical techniques is one of the strongest drivers of the kidney stone management market. Procedures such as ureteroscopic lithotripsy, extracorporeal shock wave lithotripsy, and percutaneous nephrolithotomy are widely adopted due to reduced post-operative pain, lower complication rates, shorter hospital stays, and quicker recovery times. Surgeons are shifting away from open surgeries, leading to higher procedural volumes and greater device utilization.

Technological advancements in flexible fiber-optic ureteroscopes, digital imaging systems, and laser lithotripsy platforms are improving procedural accuracy and clinical success rates. Innovations such as high-energy holmium laser systems allow efficient stone fragmentation with minimal damage to surrounding tissues, improving treatment outcomes and driving hospital investment in advanced urology equipment.

Market Restraints and Challenges

Despite technological progress, certain treatment approaches present limitations. Shock wave lithotripsy is associated with risks such as renal tissue damage, bleeding, urinary obstruction, and possible increases in arterial blood pressure. These side effects can restrict patient eligibility and physician preference in certain cases, limiting broader adoption in complex stone conditions.

Cost barriers also affect adoption in developing regions, where healthcare budgets remain constrained and access to advanced surgical devices is limited. In addition, lack of specialized urology infrastructure in rural healthcare facilities reduces procedural availability, particularly in emerging economies.

Impact of COVID-19 on the Market

The COVID-19 pandemic caused temporary disruption to kidney stone management services. Elective urology procedures were postponed, diagnostic visits declined, and healthcare resources were redirected toward emergency and infectious disease management. Medical device manufacturing and global supply chains also experienced slowdowns, resulting in delayed equipment procurement. Although demand recovered post-pandemic, procedural backlogs created short-term fluctuations in device utilization across hospitals and ambulatory surgical centers.

Segmentation Analysis

By Type

The market is segmented into lithotripsy, ureteroscopy, and percutaneous nephrolithotomy (PCNL). Among these, the ureteroscopy segment dominated with a 51.59% market share in 2026. This dominance is supported by high stone clearance rates, reduced recurrence risk, and strong suitability for both small and moderate-sized stones. Continuous improvements in scope flexibility, imaging clarity, and laser compatibility further strengthen adoption.

By End User

Based on end users, the market includes hospitals, specialty clinics, and ambulatory surgical centers. Hospitals accounted for the largest share at 55.89% in 2026, driven by higher patient volumes, access to full surgical facilities, and broader insurance coverage. Specialty clinics are gaining traction due to focused urology expertise, growing outpatient procedural capacity, and favorable reimbursement policies in selected countries.

Regional Market Insights

North America

North America recorded a market size of USD 0.71 billion in 2025, maintaining regional leadership due to strong diagnostic penetration, favorable reimbursement systems, and rapid technology adoption. The U.S. kidney stone management market is projected to reach USD 0.68 billion by 2026, supported by widespread use of minimally invasive procedures and high disease prevalence.

Europe

Europe holds the second-largest regional share, driven by rising incidence rates and increasing healthcare expenditures. By 2026, the Germany market is projected to reach USD 0.16 billion, while the UK market is projected to reach USD 0.07 billion, supported by high acceptance of advanced urology devices and structured referral systems within public healthcare networks.

Asia Pacific

Asia Pacific is expected to show strong expansion due to large patient populations and improving healthcare access. By 2026, the China market is projected to reach USD 0.14 billion, the Japan market USD 0.11 billion, and the India market USD 0.05 billion. Rising awareness, increasing hospital investments, and expanding private healthcare services are strengthening device demand across urban treatment centers.

Latin America and Middle East & Africa

These regions are experiencing gradual growth supported by improving healthcare infrastructure and increasing disease awareness. Expansion of hospital networks and international medical device partnerships is improving access to kidney stone management technologies.

Competitive Landscape and Industry Developments

The market is led by companies such as Boston Scientific Corporation, Olympus Corporation, KARL STORZ SE & Co. KG, Richard Wolf GmbH, Cook Medical, Lumenis, and EDAP TMS. These players maintain strong global presence through diversified product portfolios, continuous innovation, and strategic partnerships.

Key industry developments include the launch of advanced flexible ureteroscopic retrieval systems and high-energy laser platforms designed to improve procedural efficiency and safety. Expansion of laser lithotripsy technologies in emerging markets has further increased device penetration and competitive positioning among global manufacturers.

Report Coverage

The kidney stone management market report provides in-depth analysis of market size, segmentation by type and end user, regional performance, technology trends, competitive strategies, and recent product launches. The report evaluates growth factors, operational challenges, healthcare policy influences, and procedural adoption patterns shaping market development between 2025, 2026, and 2034, offering comprehensive insights for manufacturers, healthcare providers, investors, and strategic planners operating within the urology device industry.

Conclusion

The kidney stone management market is demonstrating steady and sustained expansion, with the global market valued at USD 1.98 billion in 2025, projected to reach USD 2.09 billion in 2026, and expected to grow further to USD 3.37 billion by 2034. This growth trajectory is strongly supported by the rising global prevalence of kidney stone disease, high recurrence rates, and increasing adoption of minimally invasive treatment procedures across healthcare systems.

Technological advancements in ureteroscopy, laser lithotripsy, and digital imaging platforms are significantly improving procedural success rates, reducing complications, and shortening recovery times, which is encouraging hospitals and specialty clinics to upgrade their urology equipment. The dominance of the ureteroscopy segment, holding 51.59% market share in 2026, and the strong position of hospitals with 55.89% share in 2026, highlight the continued preference for advanced, facility-based treatment options.

Segmentation By Type

  • Lithotripsy
  • Ureteroscopy
  • Percutaneous Nephrolithonomy (PCNL)

By End User

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers

By Geography

  • North America (the U.S., and Canada)
  • Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and the Rest of Europe)
  • Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia- Pacific)
  • Latin America (Brazil, Mexico, and the Rest of Latin America)
  • Middle East & Africa (South Africa, GCC, and the Rest of Middle East & Africa)

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities

4. Key Insights

  • 4.1. Reimbursement Scenario by Key Countries/Region
  • 4.2. Recent Advancements in Kidney Stone Management Devices
  • 4.3. Key Industry Trends
  • 4.4. Key Industry Developments (Mergers, Acquisitions, and Partnerships)
  • 4.5. Impact of COVID-19 on Kidney Stone Management Devices Market

5. Global Kidney Stone Management Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Key Findings / Summary
  • 5.2. Market Analysis, Insights and Forecast - By Type
    • 5.2.1. Lithotripsy
    • 5.2.2. Ureteroscopy
    • 5.2.3. Percutaneous Nephrolithonomy (PCNL)
  • 5.3. Market Analysis, Insights and Forecast - By End User
    • 5.3.1. Hospitals
    • 5.3.2. Specialty Clinics
    • 5.3.3. Ambulatory Surgical Centers
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Kidney Stone Management Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Key Findings / Summary
  • 6.2. Market Analysis - By Type
    • 6.2.1. Lithotripsy
    • 6.2.2. Ureteroscopy
    • 6.2.3. Percutaneous Nephrolithonomy (PCNL)
  • 6.3. Market Analysis - By End User
    • 6.3.1. Hospitals
    • 6.3.2. Specialty Clinics
    • 6.3.3. Ambulatory Surgical Centers
  • 6.4. Market Analysis - By Country
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe Kidney Stone Management Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Key Findings / Summary
  • 7.2. Market Analysis - By Type
    • 7.2.1. Lithotripsy
    • 7.2.2. Ureteroscopy
    • 7.2.3. Percutaneous Nephrolithonomy (PCNL)
  • 7.3. Market Analysis - By End User
    • 7.3.1. Hospitals
    • 7.3.2. Specialty Clinics
    • 7.3.3. Ambulatory Surgical Centers
  • 7.4. Market Analysis - By Country/Sub-region
    • 7.4.1. U.K.
    • 7.4.2. Germany
    • 7.4.3. France
    • 7.4.4. Spain
    • 7.4.5. Italy
    • 7.4.6. Scandinavia
    • 7.4.7. Rest of Europe

8. Asia Pacific Kidney Stone Management Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Key Findings / Summary
  • 8.2. Market Analysis - By Type
    • 8.2.1. Lithotripsy
    • 8.2.2. Ureteroscopy
    • 8.2.3. Percutaneous Nephrolithonomy (PCNL)
  • 8.3. Market Analysis - By End User
    • 8.3.1. Hospitals
    • 8.3.2. Specialty Clinics
    • 8.3.3. Ambulatory Surgical Centers
  • 8.4. Market Analysis - By Country/Sub-region
    • 8.4.1. Japan
    • 8.4.2. China
    • 8.4.3. India
    • 8.4.4. Australia
    • 8.4.5. Southeast Asia
    • 8.4.6. Rest of Asia Pacific

9. Latin America Kidney Stone Management Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Key Findings / Summary
  • 9.2. Market Analysis - By Type
    • 9.2.1. Lithotripsy
    • 9.2.2. Ureteroscopy
    • 9.2.3. Percutaneous Nephrolithonomy (PCNL)
  • 9.3. Market Analysis - By End User
    • 9.3.1. Hospitals
    • 9.3.2. Specialty Clinics
    • 9.3.3. Ambulatory Surgical Centers
  • 9.4. Market Analysis - By Country/Sub-region
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America

10. Middle East & Africa Kidney Stone Management Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Key Findings / Summary
  • 10.2. Market Analysis - By Type
    • 10.2.1. Lithotripsy
    • 10.2.2. Ureteroscopy
    • 10.2.3. Percutaneous Nephrolithonomy (PCNL)
  • 10.3. Market Analysis - By End User
    • 10.3.1. Hospitals
    • 10.3.2. Specialty Clinics
    • 10.3.3. Ambulatory Surgical Centers
  • 10.4. Market Analysis - By Country/Sub-region
    • 10.4.1. GCC Countries
    • 10.4.2. South Africa
    • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Key Industry Developments
  • 11.2. Global Market Share Analysis (2021)
  • 11.3. Competition Dashboard
  • 11.4. Comparative Analysis - Major Players
  • 11.5. Company Profiles (Overview, Products & Services, SWOT analysis, Recent developments, Strategies, Financials (based on availability))
    • 11.5.1. Cook Medical Inc.
      • 11.5.1.1. Overview,
      • 11.5.1.2. Products & Services,
      • 11.5.1.3. SWOT analysis,
      • 11.5.1.4. Recent developments,
      • 11.5.1.5. Strategies,
      • 11.5.1.6. Financials (based on availability)
    • 11.5.2. Olympus Corp.
      • 11.5.2.1. Overview,
      • 11.5.2.2. Products & Services,
      • 11.5.2.3. SWOT analysis,
      • 11.5.2.4. Recent developments,
      • 11.5.2.5. Strategies,
      • 11.5.2.6. Financials (based on availability)
    • 11.5.3. C.R. Bard Inc.
      • 11.5.3.1. Overview,
      • 11.5.3.2. Products & Services,
      • 11.5.3.3. SWOT analysis,
      • 11.5.3.4. Recent developments,
      • 11.5.3.5. Strategies,
      • 11.5.3.6. Financials (based on availability)
    • 11.5.4. Boston Scientific Corporation
      • 11.5.4.1. Overview,
      • 11.5.4.2. Products & Services,
      • 11.5.4.3. SWOT analysis,
      • 11.5.4.4. Recent developments,
      • 11.5.4.5. Strategies,
      • 11.5.4.6. Financials (based on availability)
    • 11.5.5. STORZ MEDICAL AG
      • 11.5.5.1. Overview,
      • 11.5.5.2. Products & Services,
      • 11.5.5.3. SWOT analysis,
      • 11.5.5.4. Recent developments,
      • 11.5.5.5. Strategies,
      • 11.5.5.6. Financials (based on availability)
    • 11.5.6. Richard Wolf GmbH
      • 11.5.6.1. Overview,
      • 11.5.6.2. Products & Services,
      • 11.5.6.3. SWOT analysis,
      • 11.5.6.4. Recent developments,
      • 11.5.6.5. Strategies,
      • 11.5.6.6. Financials (based on availability)
    • 11.5.7. Lumenis
      • 11.5.7.1. Overview,
      • 11.5.7.2. Products & Services,
      • 11.5.7.3. SWOT analysis,
      • 11.5.7.4. Recent developments,
      • 11.5.7.5. Strategies,
      • 11.5.7.6. Financials (based on availability)
    • 11.5.8. EDAP TMS
      • 11.5.8.1. Overview,
      • 11.5.8.2. Products & Services,
      • 11.5.8.3. SWOT analysis,
      • 11.5.8.4. Recent developments,
      • 11.5.8.5. Strategies,
      • 11.5.8.6. Financials (based on availability)
    • 11.5.9. DirexGroup
      • 11.5.9.1. Overview,
      • 11.5.9.2. Products & Services,
      • 11.5.9.3. SWOT analysis,
      • 11.5.9.4. Recent developments,
      • 11.5.9.5. Strategies,
      • 11.5.9.6. Financials (based on availability)
    • 11.5.10. Other prominent players
      • 11.5.10.1. Overview,
      • 11.5.10.2. Products & Services,
      • 11.5.10.3. SWOT analysis,
      • 11.5.10.4. Recent developments,
      • 11.5.10.5. Strategies,
      • 11.5.10.6. Financials (based on availability)

12. Strategic Recommendations

List of Tables

  • Table 1: Global Kidney Stone Management Market Revenue (US$ Bn) Forecast, by Type, 2021-2034
  • Table 2: Global Kidney Stone Management Market Revenue (US$ Bn) Forecast, by End-user, 2021-2034
  • Table 3: Global Kidney Stone Management Market Revenue (US$ Bn) Forecast, by Region, 2021-2034
  • Table 4: North America Kidney Stone Management Market Revenue (US$ Bn) Forecast, by Type, 2021-2034
  • Table 5: North America Kidney Stone Management Market Revenue (US$ Bn) Forecast, by End-user, 2021-2034
  • Table 6: North America Kidney Stone Management Market Revenue (US$ Bn) Forecast, By Country, 2021-2034
  • Table 7: Europe Kidney Stone Management Market Revenue (US$ Bn) Forecast, by Type, 2021-2034
  • Table 8: Europe Kidney Stone Management Market Revenue (US$ Bn) Forecast, by End-user, 2021-2034
  • Table 9: Europe Kidney Stone Management Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2021-2034
  • Table 10: Asia Pacific Kidney Stone Management Market Revenue (US$ Bn) Forecast, by Type, 2021-2034
  • Table 11: Asia Pacific Kidney Stone Management Market Revenue (US$ Bn) Forecast, by End-user, 2021-2034
  • Table 12: Asia Pacific Kidney Stone Management Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2021-2034
  • Table 13: Latin America Kidney Stone Management Market Revenue (US$ Bn) Forecast, by Type, 2021-2034
  • Table 14: Latin America Kidney Stone Management Market Revenue (US$ Bn) Forecast, by End-user, 2021-2034
  • Table 15: Latin America Kidney Stone Management Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2021-2034
  • Table 16: Middle East & Africa Kidney Stone Management Market Revenue (US$ Bn) Forecast, by Type, 2021-2034
  • Table 17: Middle East & Africa Kidney Stone Management Market Revenue (US$ Bn) Forecast, by End-user, 2021-2034
  • Table 18: Middle East & Africa Kidney Stone Management Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Kidney Stone Management Market Revenue Breakdown (US$ Bn, %) by Region, 2025& 2034
  • Figure 2: Global Kidney Stone Management Market Value Share (%), by Type, 2025& 2034
  • Figure 3: Global Kidney Stone Management Market Forecast (US$ Bn), by Lithotripsy, 2021-2034
  • Figure 4: Global Kidney Stone Management Market Forecast (US$ Bn), by Ureteroscopy, 2021-2034
  • Figure 5: Global Kidney Stone Management Market Forecast (US$ Bn), by Percutaneous Nephrolithonomy (PCNL), 2021-2034
  • Figure 6: Global Kidney Stone Management Market Value Share (%), by End-user, 2025& 2034
  • Figure 7: Global Kidney Stone Management Market Forecast (US$ Bn), by Hospitals, 2021-2034
  • Figure 8: Global Kidney Stone Management Market Forecast (US$ Bn), by Specialty Clinics, 2021-2034
  • Figure 9: Global Kidney Stone Management Market Forecast (US$ Bn), by Ambulatory Surgical Centers, 2021-2034
  • Figure 10: Global Kidney Stone Management Market Value (US$ Bn), by Region, 2025& 2034
  • Figure 11: North America Kidney Stone Management Market Value (US$ Bn), by Type, 2025& 2034
  • Figure 12: North America Kidney Stone Management Market Value Share (%), by Type, 2025
  • Figure 13: North America Kidney Stone Management Market Value (US$ Bn), by End-user, 2025& 2034
  • Figure 14: North America Kidney Stone Management Market Value Share (%), by End-user, 2025
  • Figure 15: North America Kidney Stone Management Market Value (US$ Bn), By Country, 2025& 2034
  • Figure 16: North America Kidney Stone Management Market Value Share (%), By Country, 2025
  • Figure 17: Europe Kidney Stone Management Market Value (US$ Bn), by Type, 2025& 2034
  • Figure 18: Europe Kidney Stone Management Market Value Share (%), by Type, 2025
  • Figure 19: Europe Kidney Stone Management Market Value (US$ Bn), by End-user, 2025& 2034
  • Figure 20: Europe Kidney Stone Management Market Value Share (%), by End-user, 2025
  • Figure 21: Europe Kidney Stone Management Market Value (US$ Bn), By Country/ Sub-region, 2025& 2034
  • Figure 22: Europe Kidney Stone Management Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 23: Asia Pacific Kidney Stone Management Market Value (US$ Bn), by Type, 2025& 2034
  • Figure 24: Asia Pacific Kidney Stone Management Market Value Share (%), by Type, 2025
  • Figure 25: Asia Pacific Kidney Stone Management Market Value (US$ Bn), by End-user, 2025& 2034
  • Figure 26: Asia Pacific Kidney Stone Management Market Value Share (%), by End-user, 2025
  • Figure 27: Asia Pacific Kidney Stone Management Market Value (US$ Bn), By Country/ Sub-region, 2025& 2034
  • Figure 28: Asia Pacific Kidney Stone Management Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 29: Latin America Kidney Stone Management Market Value (US$ Bn), by Type, 2025& 2034
  • Figure 30: Latin America Kidney Stone Management Market Value Share (%), by Type, 2025
  • Figure 31: Latin America Kidney Stone Management Market Value (US$ Bn), by End-user, 2025& 2034
  • Figure 32: Latin America Kidney Stone Management Market Value Share (%), by End-user, 2025
  • Figure 33: Latin America Kidney Stone Management Market Value (US$ Bn), By Country/ Sub-region, 2025& 2034
  • Figure 34: Latin America Kidney Stone Management Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 35: Middle East & Africa Kidney Stone Management Market Value (US$ Bn), by Type, 2025& 2034
  • Figure 36: Middle East & Africa Kidney Stone Management Market Value Share (%), by Type, 2025
  • Figure 37: Middle East & Africa Kidney Stone Management Market Value (US$ Bn), by End-user, 2025& 2034
  • Figure 38: Middle East & Africa Kidney Stone Management Market Value Share (%), by End-user, 2025
  • Figure 39: Middle East & Africa Kidney Stone Management Market Value (US$ Bn), By Country/ Sub-region, 2025& 2034
  • Figure 40: Middle East & Africa Kidney Stone Management Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 41: Global Kidney Stone Management Market Share (%), By Company, 2025